Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Practice

A 68-year-old woman with sleep-onset insomnia

Norman Wolkove and Marc Baltzan
CMAJ November 19, 2013 185 (17) 1517-1519; DOI: https://doi.org/10.1503/cmaj.130260
Norman Wolkove
Department of Medicine (Wolkove); and Department of Epidemiology, Biostatistics and Occupational Health (Baltzan), Mount Sinai Hospital, McGill University, Montréal, Que.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: nwolkove@pne.jgh.mcgill.ca
Marc Baltzan
Department of Medicine (Wolkove); and Department of Epidemiology, Biostatistics and Occupational Health (Baltzan), Mount Sinai Hospital, McGill University, Montréal, Que.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

See also review article by McMillan and colleagues on page 1499 and at www.cmaj.ca/lookup/doi/10.1503/cmaj.130025

A 68-year-old woman, who smokes 1 package of cigarettes daily, presents with fatigue, daytime sleepiness and difficulty falling asleep at night. She reports that, for as long as she can remember, her legs “absolutely needed to move” at bedtime. She has not experienced leg pain or cramps but describes a “prickly feeling under the skin.” Examinations, including neurologic evaluation, reveal no abnormalities. The results of a complete blood count were within normal limits, and her serum ferritin level was 52 (normal 18–160) μg/L.

What is the most likely diagnosis?

Primary restless legs syndrome is the most likely diagnosis. Restless legs syndrome is a neurologic movement disorder that may adversely affect sleep, and thereby result in daytime fatigue, somnolence and a reduced quality of life.1–4 This condition has also been associated with hypertension and cardiovascular disease.4 The pathophysiology of restless legs syndrome is incompletely understood. However, dopamine dysfunction in the central nervous system and iron deficiency in the brain have been implicated.1–5

Sleep-onset insomnia is typical. Patients describe an overwhelming urge to move, accompanied by unpleasant sensations in their lower limbs. The sensations are often described as “creeping,” “burning” or “tingling.” These symptoms appear at rest, usually in the evening or at bedtime, and are improved by movement. Patients typically describe voluntarily moving their limbs, stretching, walking or pacing to find relief. Symptoms may also occur during the night, thereby interrupting sleep, and they may occur nightly or on an intermittent basis.1–4 Restless legs syndrome is common, affecting 5%–15% of the population, yet it is frequently undiagnosed or mistaken for other conditions.1,3,4 Women are affected more often than men, and the prevalence increases with age.1,3,4 Over half of patients with primary restless legs syndrome have a family history, and a genetic trait with autosomal dominant transmission has been hypothesized.1,4

Restless legs syndrome may also be associated with other conditions, including diabetes, arthritis, Parkinson disease, chronic renal failure, iron deficiency and pregnancy (secondary restless legs syndrome).1,3,4 Drugs such as antihistamines, selective serotonin reuptake inhibitors, tricyclic antidepressants and dopamine antagonists can provoke or exacerbate restless legs syndrome.1

Other conditions with lower limb symptoms that can be confused with restless legs syndrome include akathisia, leg cramps, peripheral neuropathy, lumbosacral radiculopathy, vascular diseases and the syndrome of painful legs and moving toes.1,3,4 Akathisia is characterized by a general restlessness; the sensory complaints of restless legs syndrome are absent, and symptoms usually occur during the day.1,3,4 Common leg cramps that occur at night tend to be unilateral, may wake patients from sleep and are described as palpable involuntary muscle contractions.1,3,4 Peripheral neuropathy and the sensory-motor changes of lumbosacral disc disease may be distinguished by an abnormal neurologic exam and are not associated with an urge to move.1,3,4 Patients with arterial or venous peripheral vascular disease have symptoms that do not have a circadian pattern, and examination may show an absent or diminished pulse, peripheral edema and skin changes.1,3,4 The syndrome of painful legs and moving toes is characterized by involuntary flexion and extension of the toes in the context of trauma to the spinal cord, nerve roots or cauda equina. Both the urge to move and a circadian pattern are absent.1,3,4

How can the diagnosis of restless legs syndrome be confirmed?

The diagnosis is based on the typical clinical history. The results of a physical examination are usually normal unless there is an underlying predisposing condition.1,4 The National Institutes of Health state that the following 4 criteria are essential for diagnosing restless legs syndrome: an urge to move the legs usually accompanied by, or caused by, uncomfortable and unpleasant sensations in the legs; unpleasant sensations that begin or worsen during periods of rest or inactivity; unpleasant sensations that are partially or totally relieved by movement; and unpleasant sensations that are worse in the evening or at night compared with during the day or that only occur in the evening or at night.6 Supportive but not essential features include a positive family history, response to dopaminergic treatment, and the presence of periodic limb movements.

Are additional investigations necessary?

There is no specific laboratory test for restless legs syndrome. However, laboratory tests may reveal secondary causes.

Investigations should include tests for iron levels, because iron deficiency (with or without anemia) is common among those with restless legs syndrome.1–4 A sleep study (polysomnography) is not necessary for diagnosis, but it may show periodic limb movements, which may be present in 80%–90% of patients with restless legs syndrome.4 Periodic limb movement disorder is characterized by repetitive movements of the extremities (usually the legs), resulting in poor quality of sleep and insomnia. The rhythmic muscular jerks may involve extension of the big toe and can include flexion of the ankle, knee and hip.3,4

The principal indications for polysomnography among patients with suspected restless legs syndrome include atypical symptoms, marked daytime somnolence (to rule out other sleep disorders, such as obstructive sleep apnea and periodic limb movements) and if there has been an inadequate response to treatment.7

What are the management options in this patient’s case?

Although not supported by clinical trials, most clinicians recommend avoiding alcohol, caffeine and cigarette smoke.3,4 In a randomized controlled study, starting an exercise program was effective in improving the symptoms of restless legs syndrome.8

Pharmacologic treatment may not be necessary for those with mild symptoms. Other patients may only require treatment on an intermittent basis, whereas those who have nightly symptoms, such as this patient, usually require long-term therapy.

First-line prescription therapy includes dopaminergic agents (Box 1).9–11 Meta-analyses have shown that dopaminergic agents have moderate efficacy in the treatment of restless legs syndrome.9–11 Opioids, benzodiazepines and antiepileptics are second-line choices. Detailed management guidelines based on systematic reviews and meta-analyses have recently been published by the American Academy of Sleep Medicine.11

DrugsComments
Dopaminergic agents (first line)
Dopamine precursors
 Carbidopa-levodopa
  • Useful on intermittent or as-needed basis

  • Use before bedtime

  • Beware of “augmentation” (reduced therapeutic effect or worsening with time)

Dopamine agonists
 Pramipexole, ropinirole
  • Useful in moderate to severe cases

  • Slow dosage increases recommended

  • May cause nausea, somnolence

  • Best for patients with nightly symptoms

  • May cause augmentation

Benzodiazepines, opioids (second line)
Clonazepam, temazepam
  • For intermittent symptoms

  • May be useful when other medications are not tolerated

  • May improve sleep

Codeine, hydrocodone, oxycodone
  • May help with sleep onset

  • Adverse effects include constipation, urinary retention and cognitive changes

  • Tolerance and dependence are possible

Anticonvulsants (second line)
Gabapentin, carbamazepine
  • Can be considered if dopamine agonists have failed

  • May be useful in cases with coexisting peripheral neuropathy

Box 1: Pharmacologic treatment of restless legs syndrome1–4,9–11

Iron supplementation has been recommended for patients with a ferritin level of 50 μg/L or lower and may improve symptoms for some patients.1,3 However, a recent Cochrane review concluded that there is insufficient evidence to determine if iron therapy is beneficial for the treatment of restless legs syndrome.12

The case revisited

No associated illness was found, and we concluded that the patient had primary restless legs syndrome. She was advised to stop smoking and to begin an exercise program. She was prescribed pramipexole (0.125 mg 2–3 hours before bedtime, later increased to 0.5 mg nightly), which resulted in improved symptoms and sleep.

Footnotes

  • Competing interests: None declared.

  • Contributors: Both authors contributed to the conception and design and to the writing and revising of the manuscript. Both authors approved the final version submitted for publication.

References

  1. ↵
    1. Ekbom K,
    2. Ulfberg J
    . Restless legs syndrome. J Intern Med 2009;266:419–31.
    OpenUrlCrossRefPubMed
  2. National Heart. Lung and Blood Institute working group on restless legs syndrome. Am Fam Physician 2000;62:108–14.
    OpenUrlPubMed
  3. ↵
    1. Natarajan R
    . Review of periodic limb movement and restless leg syndrome. J Postgrad Med 2010;56: 157–62.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Bogan RK,
    2. Cheray JA
    . Restless legs syndrome: a review of diagnosis and management in primary care. Postgrad Med 2013;125:99–111.
    OpenUrlCrossRef
  5. ↵
    1. Mizuno S,
    2. Mihara T,
    3. Miyaoka T,
    4. et al
    . CSF iron, ferritin and transferrin levels in restless legs syndrome. J Sleep Res 2005;14:43–7.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Allen RP,
    2. Picchietti D,
    3. Henig WA,
    4. et al
    . Restless legs syndrome: diagnostic criteria, special considerations and epidemiology. A report from the Restless Legs Syndrome Diagnosis and Epidemiology Workshop at the National Institute of Health. Sleep Med 2003;4:101–19.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Hornyak M,
    2. Kotterba S,
    3. Trenkwalder C
    members of the study group “motor disorders” of the German Sleep Society. Indications for performing polysomnography in the diagnosis and treatment of restless legs syndrome. Somnologie 2001;5:159–62.
    OpenUrlCrossRef
  8. ↵
    1. Aukerman MM,
    2. Aukerman D,
    3. Bayard M,
    4. et al
    . Exercise and restless legs syndrome: a randomized controlled trial. J Am Board Fam Med 2006;19:487–93.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Wilt TJ,
    2. MacDonald R,
    3. Ouellette J,
    4. et al
    . Pharmacologic therapy for primary restless legs syndrome: a systematic review and meta-analysis. JAMA Intern Med 2013;173:496–505.
    OpenUrlCrossRefPubMed
    1. Scholz H,
    2. Trenkwalder C,
    3. Kohnen R,
    4. et al
    . Dopamine agonists for restless legs syndrome. Cochrane Database Syst Rev 2011;(3):CD006009.
  10. ↵
    1. Aurora RN,
    2. Kristo DA,
    3. Bista SR,
    4. et al
    . The treatment of restless legs syndrome and periodic limb movement disorder in adults — an update for 2012: practice parameters with an evidence-based systematic review and meta-analysis: an American Academy of Sleep Medicine Clinical Practice Guideline. Sleep 2012;35:1039–62.
    OpenUrlPubMed
  11. ↵
    1. Trotti LM,
    2. Bhadriraju S,
    3. Becker LA
    . Iron for restless legs syndrome. Cochrane Database Syst Rev 2012;(5):CD007834.
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 185 (17)
CMAJ
Vol. 185, Issue 17
19 Nov 2013
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A 68-year-old woman with sleep-onset insomnia
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
A 68-year-old woman with sleep-onset insomnia
Norman Wolkove, Marc Baltzan
CMAJ Nov 2013, 185 (17) 1517-1519; DOI: 10.1503/cmaj.130260

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
A 68-year-old woman with sleep-onset insomnia
Norman Wolkove, Marc Baltzan
CMAJ Nov 2013, 185 (17) 1517-1519; DOI: 10.1503/cmaj.130260
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • What is the most likely diagnosis?
    • How can the diagnosis of restless legs syndrome be confirmed?
    • Are additional investigations necessary?
    • What are the management options in this patient’s case?
    • The case revisited
    • Footnotes
    • References
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF

Related Articles

  • Management of insomnia and long-term use of sedative-hypnotic drugs in older patients
  • Highlights
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • A blistering variant of phlegmasia cerulea dolens from underlying squamous cell lung cancer
  • Parechovirus infections in infants
  • Radiation dermatitis in a patient treated for hepatocarcinoma
Show more Practice

Similar Articles

Collections

  • Topics
    • Family medicine, general practice, primary care
    • Sleep medicine

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire